
Oncologist

No OPD information available
Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma
T-Cell Lymphoma
Anaplastic Large Cell Lymphoma
B-Cell Lymphoma
Chronic B-Cell Leukemia (CBCL)
Chronic Lymphocytic Leukemia (CLL)
Cutaneous T-Cell Lymphoma (CTCL)
Mycosis Fungoides
Sezary Syndrome
Small Lymphocytic Lymphoma (SLL)
Dejan Radeski is a male medical professional who specializes in treating various types of lymphoma and leukemia, such as Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, and Chronic Lymphocytic Leukemia, among others.
Dejan Radeski helps patients by using special skills and treatments to fight these diseases. He is known for his ability to communicate effectively with patients, making them feel comfortable and confident in his care. Patients trust him because he listens to their concerns and explains things in a way they can understand.
To stay updated with the latest medical knowledge, Dejan Radeski regularly reads research papers and attends conferences. This helps him provide the best possible care to his patients. He also collaborates with other medical professionals to share knowledge and improve patient outcomes.
Dejan Radeski's work has had a positive impact on many patients' lives. His research on indolent relapse after aggressive B-cell lymphoma has been published in a medical journal. He has also been involved in clinical trials, such as the SOLAR study, which aimed to investigate the efficacy and safety of a treatment for Cutaneous T-Cell Lymphoma.
Overall, Dejan Radeski is a dedicated healthcare provider who is committed to improving the lives of his patients. His expertise, compassionate approach, and involvement in research make him a trusted and respected figure in the field of oncology.
Enrollment Status: Terminated
Published: April 08, 2022
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
